Seagen announces resignation of president, chairman & ceo clay siegall

Bothell, wash.--(business wire)--seagen inc. (nasdaq: sgen) today announced that the board of directors yesterday accepted the resignation of clay siegall, ph.d., as president, ceo and member of the board of directors. felix j. baker, ph.d., formerly lead independent director, has been appointed chair of the board of directors. roger dansey, m.d., seagen's chief medical officer since 2018, will continue as interim ceo until a new ceo is found. the board had previously announced that dr. siegall
SGEN Ratings Summary
SGEN Quant Ranking